Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia
Conclusion: The present study does not distinguish between fluconazole and posaconazole as a primary effective prevention against fungal infections. More prospective studies and meta-analyses are warranted.
Source: Biomedical Journal - Category: Biomedical Science Authors: Camille DevanlayEmmanuelle Tavernier-TardyAurélie BourmaudAlexander Tuan FalkHélène RaberinSandrine MenguyDenis GuyotatNicolas MagnéJérôme Cornillon Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Biomedical Science | Candida | Chemotherapy | Fluconazole | Fungal Infections | Leukemia | Men | Study